BHC - Bausch Health Companies Inc
Close
5.93
0.060 1.012%
Share volume: 1,266,760
Last Updated: Fri 30 Aug 2024 10:00:02 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$5.87
0.06
1.02%
View ratios
| Fiscal Date | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
| Report Date | 2022-11-03 | 2023-02-23 | 2023-05-04 | 2023-08-03 | 2023-11-02 | 2024-02-22 | 2024-05-02 | 2024-08-01 | |
| Assets | |||||||||
| Total Assets | 26.298 B | 25.686 B | 25.445 B | 25.503 B | 27.064 B | 27.350 B | 26.913 B | 26.495 B | |
| Current Assets | 4.010 B | 4.247 B | 4.237 B | 4.461 B | 5.048 B | 5.596 B | 5.396 B | 5.211 B | |
| Inventories | 1.056 B | 1.090 B | 1.222 B | 1.240 B | 1.272 B | 1.544 B | 1.636 B | 1.612 B | |
| Other Current Assets | 718.000 M | 776.000 M | 796.000 M | 890.000 M | 1.048 B | 1.092 B | 957.000 M | 874.000 M | |
| Short Term Investments | 718.000 M | 776.000 M | 796.000 M | 890.000 M | 1.048 B | 1.092 B | 957.000 M | 874.000 M | |
| Total Receivables | 1.739 B | 1.790 B | 1.688 B | 1.743 B | 1.948 B | 1.998 B | 2.048 B | 2.102 B | |
| Current Cash | 486.000 M | 564.000 M | 518.000 M | 579.000 M | 760.000 M | 947.000 M | 733.000 M | 595.000 M | |
| Total Non-current Assets | 22.288 B | 21.439 B | 21.208 B | 21.042 B | 22.016 B | 21.754 B | 21.517 B | 21.284 B | |
| Property Plant Equipment | 1.507 B | 1.600 B | 1.596 B | 1.599 B | 1.584 B | 1.707 B | 1.713 B | 1.738 B | |
| Other Assets | 341.000 M | 326.000 M | 318.000 M | 325.000 M | 328.000 M | 307.000 M | 312.000 M | 329.000 M | |
| Intangible Assets | 6.024 B | 5.800 B | 5.552 B | 5.299 B | 6.728 B | 6.456 B | 6.183 B | 5.903 B | |
| Goodwill | 12.044 B | 11.547 B | 11.579 B | 11.628 B | 11.187 B | 11.183 B | 11.160 B | 11.127 B | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 26.298 B | 25.686 B | 25.445 B | 25.503 B | 27.064 B | 27.350 B | 26.913 B | 26.495 B | |
| Total liabilities | 26.823 B | 26.378 B | 26.245 B | 26.166 B | 28.244 B | 28.372 B | 28.028 B | 27.670 B | |
| Total current liabilities | 3.831 B | 3.941 B | 3.923 B | 3.967 B | 4.224 B | 4.302 B | 4.405 B | 4.369 B | |
| Accounts Payable | 486.000 M | 521.000 M | 561.000 M | 515.000 M | 569.000 M | 719.000 M | 642.000 M | 579.000 M | |
| Other liabilities | 808.000 M | 949.000 M | 965.000 M | 942.000 M | 968.000 M | 1.029 B | 976.000 M | 975.000 M | |
| Current long term debt | 411.000 M | 432.000 M | 446.000 M | 444.000 M | 536.000 M | 450.000 M | 538.000 M | 452.000 M | |
| Long term debt | 20.804 B | 20.334 B | 20.207 B | 20.108 B | 21.894 B | 21.938 B | 21.536 B | 21.208 B | |
| Other liabilities | 808.000 M | 949.000 M | 965.000 M | 942.000 M | 968.000 M | 1.029 B | 976.000 M | 975.000 M | |
| Minority interest | 958.000 M | 952.000 M | 945.000 M | 934.000 M | 945.000 M | 940.000 M | 941.000 M | 948.000 M | |
| Total Shareholder equity | -525.000 M | -692.000 M | -800.000 M | -663.000 M | -1.180 B | -1.022 B | -1.115 B | -1.175 B | |
| Common stock | 362.500 M | 362.500 M | 363.300 M | 364.800 M | 365.400 M | 366.100 M | 366.800 M | 367.900 M | |
| Retained earnings | -8.776 B | -9.186 B | -9.387 B | -9.361 B | -9.739 B | -9.778 B | -9.842 B | -9.832 B |